chr5-13716687-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000265104.5(DNAH5):c.12709G>A(p.Val4237Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000127 in 1,609,960 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V4237F) has been classified as Likely benign.
Frequency
Consequence
ENST00000265104.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAH5 | NM_001369.3 | c.12709G>A | p.Val4237Ile | missense_variant | 74/79 | ENST00000265104.5 | NP_001360.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH5 | ENST00000265104.5 | c.12709G>A | p.Val4237Ile | missense_variant | 74/79 | 1 | NM_001369.3 | ENSP00000265104 | P4 | |
DNAH5 | ENST00000681290.1 | c.12664G>A | p.Val4222Ile | missense_variant | 74/79 | ENSP00000505288 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000342 AC: 52AN: 152206Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000156 AC: 39AN: 250650Hom.: 0 AF XY: 0.0000738 AC XY: 10AN XY: 135492
GnomAD4 exome AF: 0.000105 AC: 153AN: 1457638Hom.: 0 Cov.: 30 AF XY: 0.000109 AC XY: 79AN XY: 725514
GnomAD4 genome AF: 0.000341 AC: 52AN: 152322Hom.: 0 Cov.: 33 AF XY: 0.000349 AC XY: 26AN XY: 74484
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 06, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at